NovaBridge Biosciences (NBP) Form 6-K — Jun 16, 2026

NovaBridge Biosciences dismissed PricewaterhouseCoopers LLP as its independent registered public accounting firm effective June 16, 2026. The company simultaneously engaged Deloitte Touche Tohmatsu Certified Public Accountants LLP to serve as its new auditor for the fiscal year ending December 31, 2026. The company reported that PwC's audit reports for the fiscal years ended December 31, 2025 and 2024 contained no adverse opinions or qualifications. There were no disagreements between the company and PwC regarding accounting principles, financial statement disclosure, or auditing scope.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.